Viewing Study NCT00936650


Ignite Creation Date: 2025-12-24 @ 5:08 PM
Ignite Modification Date: 2026-01-27 @ 6:20 AM
Study NCT ID: NCT00936650
Status: COMPLETED
Last Update Posted: 2013-05-08
First Post: 2009-06-04
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study to Assess the Efficacy and Safety of Twice-Daily Dose Regimens of an Oral Calcimimetic Agent AMG 073 (Cinacalcet) in Primary Hyperparathyroidism (PHPT)
Sponsor: Amgen
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: 990120
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: None
Responsible Party Affiliation:
Old Name: Global Development Leader
Old Organization: Amgen Inc.

Collaborators